MANDY CRIADO: Open Payments
NPI 1902955271 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 24 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $251 |
| Galderma Laboratories, L.P. | 2 | $137 |
| Novartis Pharmaceuticals Corporation | 2 | $106 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| Amgen Inc. | 1 | $85 |
| LEO Pharma Inc. | 2 | $50 |
| LNHC, Inc | 2 | $45 |
| ABBVIE INC. | 2 | $36 |
| GENZYME CORPORATION | 2 | $32 |
| Organogenesis Inc. | 1 | $25 |
Products named: TREMFYA, NEMLUVIO, Rhapsido, OTEZLA, DUPIXENT, ANZUPGO, ZELSUVMI, LIBTAYO.
Industry payments across MD — which companies pay providers there.
